Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial

2011 ◽  
Vol 27 (2) ◽  
pp. 219-226 ◽  
Author(s):  
Robert Chinnapongse ◽  
Kristen Gullo ◽  
Paul Nemeth ◽  
Yuxin Zhang ◽  
Lynn Griggs
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Type ◽  
Double Blind Trial ◽  
Type B ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Blind Trial ◽  
Botulinum Toxin Type B

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

Neurology ◽  
1997 ◽  
Vol 49 (3) ◽  
pp. 701-707 ◽  
Author(s):  
M. F. Lew ◽  
B. T. Adornato ◽  
D. D. Duane ◽  
D. D. Dykstra ◽  
S. A. Factor ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Type ◽  
Efficacy Study ◽  
Type B ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Botulinum Toxin Type B

Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling

2009 ◽  
Vol 256 (4) ◽  
pp. 563-567 ◽  
Author(s):  
Giovanni Lagalla ◽  
Marzia Millevolte ◽  
Marianna Capecci ◽  
Leandro Provinciali ◽  
Maria Gabriella Ceravolo
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Botulinum Toxin ◽  
Botulinum Toxin Type ◽  
Type B ◽  
Botulinum Toxin Type B

The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease

2005 ◽  
Vol 21 (4) ◽  
pp. 500-509 ◽  
Author(s):  
Alexandre Castro-Caldas ◽  
Paul Delwaide ◽  
Wolfgang Jost ◽  
Marcelo Merello ◽  
Adrian Williams ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document